Exciting Advancements in Bladder Cancer Research

This chapter explores significant presentations on bladder cancer at the ASCO conference, highlighting studies like the CREST study that focuses on a PD-1 inhibitor. It emphasizes new therapies, the role of ctDNA as a prognostic marker, and the dynamic treatment landscape for bladder cancer patients.